🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Altamir Amboise (ALMP)

Paris
Currency in EUR
Disclaimer
25.70
0.00(0.00%)
Closed
ALMP Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
High dividend Yield
Fair Value
Day's Range
25.7025.80
52 wk Range
22.8028.20
Prev. Close
25.7
Open
25.7
Day's Range
25.7-25.8
52 wk Range
22.8-28.2
Volume
1,419
Average Vol. (3m)
1,821
1-Year Change
-6.55%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ALMP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
25.00
Downside
-2.72%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Altamir Amboise Company Profile

Altamir SCA, formerly known as Altamir Amboise, is a private equity investment arm of Amboise SAS, specializing in both direct and fund of fund investments, small and mid-cap companies. In direct investing, the firm specializes in middle market, buyout and growth capital investments. The firm prefers to invest in high-growth companies, diversified by size and geography. The firm prefers to invest in under-developed divisions of larger corporations. It prefers to invest in private equity funds specializing in growth capital and leverage buyouts investments from Europe, United States and Canada. The firm typically invests in the following sectors like commercial services and supplies, industrial, technology, telco, healthcare services, commercial, professional services, consumer durables and apparel, TMT, digital companies, consumer services, education services, hotel, restaurants, leisure, retail and distribution. It also invests in retail and consumer, business and financial services. In financial services firm seeks to invest in specialized finance, multi-sector holding, diversified financial services. In healthcare, it seeks to focus on companies with strong growth potential in areas such as health services (hospitalization structures, home health care and medical analysis); medical devices; in niche pharmaceutical laboratories; and companies in related activities such as dermo-cosmetics, galenic development, and services and databases for health organizations. The firm seeks to invest in unlisted companies based in Europe, with a particular focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, Netherlands, Germany and French-speaking Europe; United States and Canada and in larger emerging markets such as China, India and Brazil. In small and mid-cap companies firm prefers to invest in Continental Europe with a focus in France, Italy and Benelux, & larger size companies in Europe, North America and emerging countries like China, India and Brazil. In small and mid-cap size companies it prefers to invest with enterprise value between €50 million ($55.36 million) and €500 million ($553.6 million) and in larger size companies it prefers to invest with enterprise value between €500 million ($553.60 million) and €3000 million ($3321.62 million). It invests in funds that seek to have a majority stake in its investments or be a lead shareholder. The firm seeks to exit its investments within five years. It makes balance sheet investments. Altamir SCA was founded in 1995 and is based in Paris, France.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.